ITS

A more powerful way to test skin sensitisation

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser

"Detailed Report” feature for SkinSens ITS

Following the successful SkinSens ITS release during the Society of Toxicology annual meeting 2017, we received plenty of positive feedback and valuable suggestions for additional features.

Skin Sensitization Application

Allergic contact dermatitis (aka., skin sensitization) accounts for 20% of all contact dermatitis cases and hence has an estimated annual cost up to $200 million. It is also a public health problem...

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Latest Tweets

Douglas Connect (4 weeks ago)
Replacing and Reducing Unnecessary Animal Experiments can be accelerated by organising Current Knowledge and using… https://t.co/1KhkLkrDyW
Douglas Connect (4 weeks ago)
RT @ACEnanoH2020: OpenRiskNet project, coordinated by @DouglasConn, is developing a platform providing data and modelling tools for predict…
Douglas Connect (4 weeks ago)
OpenTox Euro 2018 in Athens, Greece - We are pleased to announce that the complete OpenTox Euro 2018 Conference Pro… https://t.co/uIZJVAlkh3
Douglas Connect (5 weeks ago)
RT @LucianFarcal: Presenting the concept and latest achievements on protocols and data management related to phys-chem characterisation of…
Douglas Connect (5 weeks ago)
Exploring AI and Machine Learning Approaches to Precision Medicine and Healthcare - Join us for discussion in Phila… https://t.co/2j9ijVonna

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com